Epstein-Barr virus-associated lymphomas

Seminars in Oncology

Volumn 42, Issue 2, 2015, Pages 291-303

  Grywalska, Ewelina ^a   Rolinski, Jacek ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS ANTIGEN; MEMBRANE PROTEIN; UNTRANSLATED RNA;

AGGRESSIVE NK CELL LEUKEMIA; ANGIOIMMUNOBLASTIC T CELL LYMPHOMA; B LYMPHOCYTE; BURKITT LYMPHOMA; CHRONIC INFLAMMATION; DISEASE ASSOCIATION; EPITHELIUM CELL; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEMATOLOGIC DISEASE; HEMATOPOIETIC CELL; HODGKIN DISEASE; HUMAN; HYDROA VACCINIFORME; IMMUNE RESPONSE; LARGE CELL LYMPHOMA; LYMPHOCYTE TRANSFORMATION; LYMPHOMA; LYMPHOMATOID GRANULOMATOSIS; NK T CELL LYMPHOMA; PLASMABLASTIC LYMPHOMA; PRIMARY EFFUSION LYMPHOMA; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; VIRUS GENOME; COMPLICATION; VIROLOGY;

EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; LYMPHOMA;

EID: 84926366434     PISSN: 00937754     EISSN: 15328708     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2014.12.030     Document Type: Review

References (107)

1. A. Arvey, I. Tempera, and K. Tsai An atlas of the Epstein-Barr virus transcriptome and epigenome reveals host-virus regulatory interactions Cell Host Microbe 12 2012 233 245
2. K. Shiley, and E. Blumberg Herpes viruses in transplant recipients: HSV, VZV, human herpes viruses, and EBV Infect Dis Clin North Am 24 2010 373 393
3. J.M. Middeldorp, A.A. Brink, and A.J. van den Brule Pathogenic roles for Epstein-Barr virus (EBV) gene products in EBV-associated proliferative disorders Crit Rev Oncol Hematol 45 2003 1 36
4. M.P. Thompson, and R. Kurzrock Epstein-Barr virus and cancer Clin Cancer Res 10 2004 803 821
5. E. Klein, N. Nagy, and A.E. Rasul EBV genome carrying B lymphocytes that express the nuclear protein EBNA-2 but not LMP-1: Type IIb latency Oncoimmunology 2 2013 e23035
6. A. Saha, and E.S. Robertson Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes Clin Cancer Res 17 2011 3056 3063
7. A.E. Rasul, N. Nagy, and E. Sohlberg Simultaneous detection of the two main proliferation driving EBV encoded proteins, EBNA-2 and LMP-1 in single B cells J Immunol Methods 385 2012 60 70
8. A. Onnis, M. Navari, and G. Antonicelli Epstein-Barr nuclear antigen 1 induces expression of the cellular microRNA hsa-miR-127 and impairing B-cell differentiation in EBV-infected memory B cells. New insights into the pathogenesis of Burkitt lymphoma Blood Cancer J 2 2012 e84
9. N. Sivachandran, C.W. Dawson, and L.S. Young Contributions of the Epstein-Barr virus EBNA1 protein to gastric carcinoma J Virol 86 2012 60 68
10. J. Zhao, H. Jin, and K.F. Cheung Zinc finger E-box binding factor 1 plays a central role in regulating Epstein-Barr virus (EBV) latent-lytic switch and acts as a therapeutic target in EBV-associated gastric cancer Cancer 118 2012 924 936
11. Y. Ito, Y. Kawamura, and S. Iwata Demonstration of type II latency in T lymphocytes of Epstein-Barr Virus-associated hemophagocytic lymphohistiocytosis Pediatr Blood Cancer 60 2013 326 328
12. L.L. Kis, N. Gerasimcik, and D. Salamon STAT6 signaling pathway activated by the cytokines IL-4 and IL-13 induces expression of the Epstein-Barr virus-encoded protein LMP-1 in absence of EBNA-2: implications for the type II EBV latent gene expression in Hodgkin lymphoma Blood 117 2011 165 174
13. I. Palma, A.E. Sanchez, and E. Jimenez-Hernandez Detection of Epstein-Barr virus and genotyping based on EBNA2 protein in Mexican patients with hodgkin lymphoma: a comparative study in children and adults Clin Lymphoma Myeloma Leuk 13 2013 266 272
14. M.R. Ghigna, T. Reineke, and P. Rince Epstein-Barr virus infection and altered control of apoptotic pathways in posttransplant lymphoproliferative disorders Pathobiology 80 2013 53 59
15. I. Ersing, K. Bernhardt, and B.E. Gewurz NF-kappaB and IRF7 pathway activation by Epstein-Barr virus latent membrane protein 1 Viruses 5 2013 1587 1606
16. N. Martis, and N. Mounier Hodgkin lymphoma in patients with HIV infection: a review Curr Hematol Malig Rep 7 2012 228 234
17. M. Roschewski, and W.H. Wilson EBV-associated lymphomas in adults Best Pract Res Clin Haematol 25 2012 75 89
18. P.A. Chabay, and M.V. Preciado EBV primary infection in childhood and its relation to B-cell lymphoma development: a mini-review from a developing region Int J Cancer 133 2013 1286 1292
19. D. Bechtel, J. Kurth, and C. Unkel Transformation of BCR-deficient germinal-center B cells by EBV supports a major role of the virus in the pathogenesis of Hodgkin and posttransplantation lymphomas Blood 106 2005 4345 4350
20. A. Nicolae, S. Pittaluga, and G. Venkataraman Peripheral T-cell lymphomas of follicular T-helper cell derivation with Hodgkin/Reed-Sternberg cells of B-cell lineage: both EBV-positive and EBV-negative variants exist Am J Surg Pathol 37 2013 816 826
21. C.Y. Ok, T.G. Papathomas, and L.J. Medeiros EBV-positive diffuse large B-cell lymphoma of the elderly Blood 122 2013 328 340
22. H.J. Delecluse, R. Feederle, and B. O'Sullivan Epstein Barr virus-associated tumours: an update for the attention of the working pathologist J Clin Pathol 60 2007 1358 1364
23. A. Saha, R. Kaul, and M. Murakami Tumor viruses and cancer biology: modulating signaling pathways for therapeutic intervention Cancer Biol Ther 10 2010 961 978
24. S. Spadavecchia, O. Gonzalez-Lopez, and K.D. Carroll Convergence of Kaposi's sarcoma-associated herpesvirus reactivation with Epstein-Barr virus latency and cellular growth mediated by the notch signaling pathway in coinfected cells J Virol 84 2010 10488 10500
25. G.L. Kelly, J. Stylianou, and J. Rasaiyaah Different patterns of Epstein-Barr virus latency in endemic Burkitt lymphoma (BL) lead to distinct variants within the BL-associated gene expression signature J Virol 87 2013 2882 2894
26. T.F. Schulz, and S. Cordes Is the Epstein-Barr virus EBNA-1 protein an oncogen? Proc Natl Acad Sci U S A 106 2009 2091 2092
27. F. Destro, F. Sforza, and M. Sicurella Proteasome inhibitors induce the presentation of an Epstein-Barr virus nuclear antigen 1-derived cytotoxic T lymphocyte epitope in Burkitt's lymphoma cells Immunology 133 2011 105 114
28. N. Sivachandran, J.Y. Cao, and L. Frappier Epstein-Barr virus nuclear antigen 1 Hijacks the host kinase CK2 to disrupt PML nuclear bodies J Virol 84 2010 11113 11123
29. J.T. Tellam, L. Lekieffre, and J. Zhong Messenger RNA sequence rather than protein sequence determines the level of self-synthesis and antigen presentation of the EBV-encoded antigen, EBNA1 PLoS Pathog 8 2012 e1003112
30. N. Nagy, and E. Klein Deficiency of the proapoptotic SAP function in X-linked lymphoproliferative disease aggravates Epstein-Barr virus (EBV) induced mononucleosis and promotes lymphoma development Immunol Lett 130 2010 13 18
31. M. Murakami, R. Kaul, and P. Kumar Nucleoside diphosphate kinase/Nm23 and Epstein-Barr virus Mol Cell Biochem 329 2009 131 139
32. V. Saridakis, Y. Sheng, and F. Sarkari Structure of the p53 binding domain of HAUSP/USP7 bound to Epstein-Barr nuclear antigen 1 implications for EBV-mediated immortalization Mol Cell 18 2005 25 36
33. J.Q. Liu, Z. Liu, and X. Zhang Increased Th17 and regulatory T cell responses in EBV-induced gene 3-deficient mice lead to marginally enhanced development of autoimmune encephalomyelitis J Immunol 188 2012 3099 3106
34. M. Fogg, J.R. Murphy, and J. Lorch Therapeutic targeting of regulatory T cells enhances tumor-specific CD8+T cell responses in Epstein-Barr virus associated nasopharyngeal carcinoma Virology 441 2013 107 113
35. R.M. Leskowitz, X.Y. Zhou, and F. Villinger CD4+and CD8+T-cell responses to latent antigen EBNA-1 and lytic antigen BZLF-1 during persistent lymphocryptovirus infection of rhesus macaques J Virol 87 2013 8351 8362
36. D. Portal, B. Zhao, and M.A. Calderwood EBV nuclear antigen EBNALP dismisses transcription repressors NCoR and RBPJ from enhancers and EBNA2 increases NCoR-deficient RBPJ DNA binding Proc Natl Acad Sci U S A 108 2011 7808 7813
37. D. Portal, H. Zhou, and B. Zhao Epstein-Barr virus nuclear antigen leader protein localizes to promoters and enhancers with cell transcription factors and EBNA2 Proc Natl Acad Sci U S A 110 2013 18537 18542
38. Y. Tokuda, M. Fukushima, and K. Nakazawa A case of primary Epstein-Barr virus-associated cutaneous diffuse large B-cell lymphoma unassociated with iatrogenic or endogenous immune dysregulation J Cutan Pathol 35 2008 666 671
39. S. Tzellos, P.B. Correia, and C.E. Karstegl A single amino acid in EBNA-2 determines superior B lymphoblastoid cell line growth maintenance by Epstein-Barr virus type 1 EBNA-2 J Virol 2014
40. R.E. White, I.J. Groves, and E. Turro Extensive co-operation between the Epstein-Barr virus EBNA3 proteins in the manipulation of host gene expression and epigenetic chromatin modification PLoS One 5 2010 e13979
41. J. Lin, E. Johannsen, and E. Robertson Epstein-Barr virus nuclear antigen 3C putative repression domain mediates coactivation of the LMP1 promoter with EBNA-2 J Virol 76 2002 232 242
42. L. Skalska, R.E. White, and G.A. Parker Induction of p16(INK4a) is the major barrier to proliferation when Epstein-Barr virus (EBV) transforms primary B cells into lymphoblastoid cell lines PLoS Pathog 9 2013 e1003187
43. B.G. Bajaj, M. Murakami, and Q. Cai Epstein-Barr virus nuclear antigen 3C interacts with and enhances the stability of the c-Myc oncoprotein J Virol 82 2008 4082 4090
44. S. Maruo, Y. Wu, and S. Ishikawa Epstein-Barr virus nuclear protein EBNA3C is required for cell cycle progression and growth maintenance of lymphoblastoid cells Proc Natl Acad Sci U S A 103 2006 19500 19505
45. J.S. Knight, N. Sharma, and E.S. Robertson Epstein-Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase Proc Natl Acad Sci U S A 102 2005 18562 18566
46. S. Maruo, Y. Wu, and T. Ito Epstein-Barr virus nuclear protein EBNA3C residues critical for maintaining lymphoblastoid cell growth Proc Natl Acad Sci U S A 106 2009 4419 4424
47. F. Yi, A. Saha, and M. Murakami Epstein-Barr virus nuclear antigen 3C targets p53 and modulates its transcriptional and apoptotic activities Virology 388 2009 236 247
48. R.J. Tierney, K.Y. Kao, and J.K. Nagra Epstein-Barr virus BamHI W repeat number limits EBNA2/EBNA-LP coexpression in newly infected B cells and the efficiency of B-cell transformation: a rationale for the multiple W repeats in wild-type virus strains J Virol 85 2011 12362 12375
49. L. Ma, X. Deng, and M. Wu Down-regulation of miRNA-204 by LMP-1 enhances CDC42 activity and facilitates invasion of EBV-associated nasopharyngeal carcinoma cells FEBS Lett 588 2014 1562 1570
50. Q. Fu, C. He, and Z.R. Mao Epstein-Barr virus interactions with the Bcl-2 protein family and apoptosis in human tumor cells J Zhejiang Univ Sci B 14 2013 8 24
51. R. Incrocci, M. McCormack, and M. Swanson-Mungerson Epstein-Barr virus LMP2A increases IL-10 production in mitogen-stimulated primary B-cells and B-cell lymphomas J Gen Virol 94 2013 1127 1133
52. G. Brocqueville, P.A. Ndour, and T.S. Ouk LMP1-induced cell death may contribute to the emergency of its oncogenic property PLoS One 8 2013 e60743
53. J.P. Graham, K.M. Arcipowski, and G.A. Bishop Differential B-lymphocyte regulation by CD40 and its viral mimic, latent membrane protein 1 Immunol Rev 237 2010 226 248
54. D. Salamon, M. Adori, and D. Ujvari Latency type-dependent modulation of Epstein-Barr virus-encoded latent membrane protein 1 expression by type I interferons in B cells J Virol 86 2012 4701 4707
55. O. Dergai, M. Dergai, and I. Skrypkina The LMP2A protein of Epstein-Barr virus regulates phosphorylation of ITSN1 and Shb adaptors by tyrosine kinases Cell Signal 25 2013 33 40
56. O. Hatton, S.L. Lambert, and L.K. Phillips Syk-induced phosphatidylinositol-3-kinase activation in Epstein-Barr virus posttransplant lymphoproliferative disorder Am J Transplant 13 2013 883 890
57. K.R. Katsumura, S. Maruo, and K. Takada EBV lytic infection enhances transformation of B-lymphocytes infected with EBV in the presence of T-lymphocytes J Med Virol 84 2012 504 510
58. M. Vockerodt, W. Wei, and E. Nagy Suppression of the LMP2A target gene, EGR-1, protects Hodgkin's lymphoma cells from entry to the EBV lytic cycle J Pathol 230 2013 399 409
59. G. Gregorovic, R. Bosshard, and C.E. Karstegl Cellular gene expression that correlates with EBER expression in Epstein-Barr Virus-infected lymphoblastoid cell lines J Virol 85 2011 3535 3545
60. N. Lee, G. Pimienta, and J.A. Steitz AUF1/hnRNP D is a novel protein partner of the EBER1 noncoding RNA of Epstein-Barr virus RNA 18 2012 2073 2082
61. K. Takada Role of EBER and BARF1 in nasopharyngeal carcinoma (NPC) tumorigenesis Semin Cancer Biol 22 2012 162 165
62. M. Samanta, D. Iwakiri, and K. Takada Epstein-Barr virus-encoded small RNA induces IL-10 through RIG-I-mediated IRF-3 signaling Oncogene 27 2008 4150 4160
63. D. Iwakiri, and K. Takada Role of EBERs in the pathogenesis of EBV infection Adv Cancer Res 107 2010 119 136
64. N. Ross, M.K. Gandhi, and J.P. Nourse The Epstein-Barr virus microRNA BART11-5p targets the early B-cell transcription factor EBF1 Am J Blood Res 3 2013 210 224
65. M.A. Epstein, and Y.M. Barr Cultivation in vitro of human lymphoblasts from Burkitt's Malignant Lymphoma Lancet 1 1964 252 253
66. L.M. Weiss, J.G. Strickler, and R.A. Warnke Epstein-Barr viral DNA in tissues of Hodgkin's disease Am J Pathol 129 1987 86 91
67. P.H. Levine, G. Pallesen, and P. Ebbesen Evaluation of Epstein-Barr virus antibody patterns and detection of viral markers in the biopsies of patients with Hodgkin's disease Int J Cancer 59 1994 48 50
68. H. Takeuchi, R. Kobayashi, and M. Hasegawa Detection of latent Epstein-Barr virus (EBV) DNA in paraffin sections of nasopharyngeal carcinomas expressing no EBV-encoded small RNAs using in situ PCR Arch Virol 142 1997 1743 1756
69. S.L. Glaser, R.J. Lin, and S.L. Stewart Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data Int J Cancer 70 1997 375 382
70. T. Zhang, Q. Fu, and D. Gao EBV associated lymphomas in 2008 WHO classification Pathol Res Pract 210 2014 69 73
71. H. Hjalgrim, J. Askling, and P. Sorensen Risk of Hodgkin's disease and other cancers after infectious mononucleosis J Natl Cancer Inst 92 2000 1522 1528
72. M. Niens, R.F. Jarrett, and B. Hepkema HLA-A∗02 is associated with a reduced risk and HLA-A∗01 with an increased risk of developing EBV+Hodgkin lymphoma Blood 110 2007 3310 3315
73. D. Lenze, L. Leoncini, and M. Hummel The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma Leukemia 25 2011 1869 1876
74. N. Mutalima, E. Molyneux, and H. Jaffe Associations between Burkitt lymphoma among children in Malawi and infection with HIV, EBV and malaria: results from a case-control study PLoS One 3 2008 e2505
75. A. Gloghini, R. Dolcetti, and A. Carbone Lymphomas occurring specifically in HIV-infected patients: from pathogenesis to pathology Semin Cancer Biol 23 2013 457 467
76. E.P. Ontiveros, A. Halwani, and L.L. Stunz A new model of LMP1-MYC interaction in B cell lymphoma Leuk Lymphoma 2014
77. L.H. Tan A practical approach to the understanding and diagnosis of lymphoma: an assessment of the WHO classification based on immunoarchitecture and immuno-ontogenic principles Pathology 41 2009 305 326
78. P. Adam, I. Bonzheim, and F. Fend Epstein-Barr virus-positive diffuse large B-cell lymphomas of the elderly Adv Anat Pathol 18 2011 349 355
79. T. Oyama, K. Yamamoto, and N. Asano Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients Clin Cancer Res 13 2007 5124 5132
80. K. Aozasa, T. Takakuwa, and S. Nakatsuka Pyothorax-associated lymphoma: a lymphoma developing in chronic inflammation Adv Anat Pathol 12 2005 324 331
81. A.B. Rickinson Co-infections, inflammation and oncogenesis: Future directions for EBV research Semin Cancer Biol 2014
82. N. Boroumand, T.L. Ly, and J. Sonstein Microscopic diffuse large B-cell lymphoma (DLBCL) occurring in pseudocysts: do these tumors belong to the category of DLBCL associated with chronic inflammation? Am J Surg Pathol 36 2012 1074 1080
83. H. Fan, S.C. Kim, and C.O. Chima Epstein-Barr viral load as a marker of lymphoma in AIDS patients J Med Virol 75 2005 59 69
84. S. Park, J. Lee, and Y.H. Ko The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma Blood 110 2007 972 978
85. A. Saglam, N. Akyurek, and F. Soylemezoglu Epstein-Barr virus frequency in primary central nervous system lymphomas in Turkey APMIS 121 2013 232 238
86. M. Deckert, A. Engert, and W. Bruck Modern concepts in the biology, diagnosis, differential diagnosis and treatment of primary central nervous system lymphoma Leukemia 25 2011 1797 1807
87. S.E. Jamal, S. Li, and R. Bajaj Primary central nervous system Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly: a clinicopathologic study of five cases Brain Tumor Pathol 2014
88. H.J. Delecluse, I. Anagnostopoulos, and F. Dallenbach Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection Blood 89 1997 1413 1420
89. W.Y. Au, A. Pang, and C. Choy Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients Blood 104 2004 243 249
90. J. Borenstein, F. Pezzella, and K.C. Gatter Plasmablastic lymphomas may occur as post-transplant lymphoproliferative disorders Histopathology 51 2007 774 777
91. L. Colomo, F. Loong, and S. Rives Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities Am J Surg Pathol 28 2004 736 747
92. M. Sakata-Yanagimoto, T. Enami, and K. Yoshida Somatic RHOA mutation in angioimmunoblastic T cell lymphoma Nat Genet 46 2014 171 175
93. M. Federico, T. Rudiger, and M. Bellei Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project J Clin Oncol 31 2013 240 246
94. H. Miyoshi, K. Sato, and D. Niino Clinicopathologic analysis of peripheral T-cell lymphoma, follicular variant, and comparison with angioimmunoblastic T-cell lymphoma: Bcl-6 expression might affect progression between these disorders Am J Clin Pathol 137 2012 879 889
95. W.Y. Au, D.D. Weisenburger, and T. Intragumtornchai Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project Blood 113 2009 3931 3937
96. C.S. Chim, E.S. Ma, and F. Loong Diagnostic cues for natural killer cell lymphoma: primary nodal presentation and the role of in situ hybridisation for Epstein-Barr virus encoded early small RNA in detecting occult bone marrow involvement J Clin Pathol 58 2005 443 445
97. X. Li, A. Babayi, and W. Sang Clinicopathologic, immunophenotypic, and EBER in situ hybridization study of extranodal natural killer/T-cell lymphoma, nasal type in amulti-ethnic groups Clin Lab 60 2014 419 425
98. R. Suzuki Pathogenesis and treatment of extranodal natural killer/T-cell lymphoma Semin Hematol 51 2014 42 51
99. Y.L. Kwong Natural killer-cell malignancies: diagnosis and treatment Leukemia 19 2005 2186 2194
100. G. Semenzato, F. Marino, and R. Zambello State of the art in natural killer cell malignancies Int J Lab Hematol 34 2012 117 128
101. J.Q. Shi, Q.X. Chen, and S.F. Li Hydroa vacciniforme-like cutaneous T-cell lymphoma Indian J Dermatol 59 2014 91 93
102. Z. Xu, and S. Lian Epstein-Barr virus-associated hydroa vacciniforme-like cutaneous lymphoma in seven Chinese children Pediatr Dermatol 27 2010 463 469
103. M. Satoh, N. Oyama, and H. Akiba Hypersensitivity to mosquito bites with natural-killer cell lymphocytosis: the possible implication of Epstein-Barr virus reactivation Eur J Dermatol 12 2002 381 384
104. M. Hong, Y.H. Ko, and K.H. Yoo EBV-positive T/NK-cell lymphoproliferative disease of childhood Korean J Pathol 47 2013 137 147
105. M. Yoshii, M. Ishida, and K. Hodohara Systemic Epstein-Barr virus-positive T-cell lymphoproliferative disease of childhood: report of a case with review of the literature Oncol Lett 4 2012 381 384
106. L. Quintanilla-Martinez, S. Kumar, and F. Fend Fulminant EBV(+) T-cell lymphoproliferative disorder following acute/chronic EBV infection: a distinct clinicopathologic syndrome Blood 96 2000 443 451
107. Y. Kasahara, A. Yachie, and K. Takei Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection Blood 98 2001 1882 1888